limited cutaneous systemic sclerosis
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
autoimmune disease
subtype of systemic sclerosis |
| gptkbp:alsoKnownAs |
lcSSc
limited scleroderma |
| gptkbp:associatedWith |
pulmonary arterial hypertension
CREST syndrome |
| gptkbp:characterizedBy |
gptkb:Raynaud's_phenomenon
telangiectasia calcinosis esophageal dysmotility anticentromere antibody sclerodactyly skin thickening distal to elbows and knees |
| gptkbp:complication |
pulmonary hypertension
digital ulcers calcinosis cutis |
| gptkbp:diagnosedBy |
gptkb:nailfold_capillaroscopy
clinical examination autoantibody testing |
| https://www.w3.org/2000/01/rdf-schema#label |
limited cutaneous systemic sclerosis
|
| gptkbp:lessLikelyToAffect |
internal organs compared to diffuse cutaneous systemic sclerosis
|
| gptkbp:onset |
adulthood
|
| gptkbp:parent |
gptkb:systemic_sclerosis
|
| gptkbp:prevalence |
more common in women
|
| gptkbp:treatment |
gptkb:proton_pump_inhibitors
immunosuppressive therapy vasodilators |
| gptkbp:bfsParent |
gptkb:systemic_sclerosis
|
| gptkbp:bfsLayer |
7
|